Burden of hepatitis B virus and syphilis co-infections and its impact on HIV treatment outcome in Ethiopia: nationwide community-based study

References

• Care P. Coinfections with hepatitis B and C virus and syphilis among HIV-infected clients in Southern Ethiopia: a cross-sectional study. HIV AIDS. 2017;9:1–11.
   Google Scholar
• Sun H, Sheng W, Tsai M, et al. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review. World J Gastroenterol. 2014;20(40):14598–14614. doi: 10.3748/wjg.v20.i40.14598.
   PubMed Web of Science ®Google Scholar
• UNAIDS, Global AIDS Monitoring 2023. UNAIDS 2022 Guid. no. 3; 2023. p. 168 [Online]. Available from: https://indicatorregistry.unaids.org/sites/default/files/2023-global-aids-monitoring_en.pdf
   Google Scholar
• Lin C-L, Kao J-H. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci. 2008;15(2):137–145. doi: 10.1007/s11373-007-9225-8.
   PubMed Web of Science ®Google Scholar
• Tao Y-T, Gao T-Y, Li H-Y, et al. Global, regional, and national trends of syphilis from 1990 to 2019: the 2019 global burden of disease study. BMC Public Health. 2023;23(1):754. doi: 10.1186/s12889-023-15510-4.
   PubMed Web of Science ®Google Scholar
• Fan L, Yu A, Zhang D, et al. Consequences of HIV/syphilis co-infection on HIV viral load and immune response to antiretroviral therapy. Infect Drug Resist. 2021;14:2851–2862. doi: 10.2147/IDR.S320648.
   PubMed Web of Science ®Google Scholar
• Gong H-Z, Hu K-R, Lyu W, et al. Risk factors for the co-infection with HIV, hepatitis B and C virus in syphilis patients. Acta Derm Venereol. 2020;100(17):1–6.
   Google Scholar
• Bagheri Amiri F, Mostafavi E, Mirzazadeh A. HIV, HBV and HCV coinfection prevalence in Iran – a systematic review and meta-analysis. PLOS One. 2016;11(3):e0151946. doi: 10.1371/journal.pone.0151946.
   PubMed Web of Science ®Google Scholar
• Saghir SAM, Al-Hassan F, Al-Salahi OSA, et al. Frequencies of HBV, HCV, HIV, and syphilis markers among blood donors: a hospital-based study in Hodeidah, Yemen. Trop J Pharm Res. 2012;11:132–136.
   Web of Science ®Google Scholar
• Getaneh Y, Lusida MI. Burden of HIV, HBV and syphilis among children in urban Ethiopia: community-based cross-sectional study. HIV Med. 2023;24(6):1–15.
   Web of Science ®Google Scholar
• Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, et al. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis. 2013;56(12):1704–1712. doi: 10.1093/cid/cit166.
   PubMed Web of Science ®Google Scholar
• Ramos JM, Toro C, Reyes F, et al. Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia. J Clin Virol. 2011;51(1):83–85. doi: 10.1016/j.jcv.2011.01.010.
   PubMed Web of Science ®Google Scholar
• Kassa D, Gebremichael G, Tilahun T, et al. Prevalence of sexually transmitted infections (HIV, hepatitis B Virus, herpes simplex virus type 2, and syphilis) in pregnant women in Ethiopia: trends over 10 years (2005–2014). Int J Infect Dis. 2019;79:50–57.
   PubMed Web of Science ®Google Scholar
• Shimelis T, Tadesse E. The diagnostic performance evaluation of the SD BIOLINE HIV/syphilis duo rapid test in Southern Ethiopia: a cross-sectional study. BMJ Open. 2015;5:1–5.
   Web of Science ®Google Scholar
• Tafuri S, Prato R, Martinelli D, et al. Prevalence of hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy. BMC Infect Dis. 2010;10:213.
   PubMed Web of Science ®Google Scholar
• Omatola CA, Lawal C, Omosayin DO, et al. Seroprevalence of HBV, HCV, and HIV and associated risk factors among apparently healthy pregnant women in Anyigba, Nigeria. Viral Immunol. 2019;32(4):186–191. doi: 10.1089/vim.2018.0140.
   PubMed Web of Science ®Google Scholar
• Getaneh Y, Khairunisa S, Husada D, et al. Burden of HIV, HBV and syphilis among children in urban Ethiopia: community‐based cross‐sectional study. HIV Med. 2023;24(6):676–690. doi: 10.1111/hiv.13457.
   PubMed Web of Science ®Google Scholar
• WHO. WHO HIV drug resistance report 2012; 2016 [cited 2016 Jan 30] [Online]. Available from: http://www.who.int/hiv/pub/drugresistance/report2012/en/
   Google Scholar
• Lau B, Sharrett AR, Kingsley LA, et al. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med. 2006;166(1):64–70. doi: 10.1001/archinte.166.1.64.
   PubMedGoogle Scholar
• Ethiopian Public Health Institute. Ethiopia population-based HIV impact assessment; 2020. Final Rep. Vol. 3 [Online]. Available from: https://phia.icap.columbia.edu/wp-content/uploads/2020/11/EPHIA_Report_280820_Web.pdf
   Google Scholar
• Ikeako LC, Ezegwui HU, Ajah LO, et al. Seroprevalence of human immunodeficiency virus, hepatitis B, hepatitis C, syphilis, and co‑infections among antenatal women in a tertiary institution in South East, Nigeria. Ann Med Health Sci Res. 2014;4(6):954–958.
   PubMedGoogle Scholar
• Alberta Health Services’ Edmonton STI Clinic. Syphilis and HIV point‐of‐care testing pilot project. Canada: National Collaborating Centre for Infectious Diseases; 2013.
   Google Scholar
• Bwalya S, Alebachew S. Analysing regional performance and disparities in health outcomes in Ethiopia. UNDP Ethiopia No. 2; 2012.
   Google Scholar
• Humphreys E, Chang LW, Harris J. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy. Cochrane Database Syst Rev. 2009;2010(4):CD006517.
   Google Scholar
• Ross EL, Tanser F, Pei PP, et al. The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials. HIV Clin Trials. 2014;15(5):185–198.
   PubMed Web of Science ®Google Scholar
• Vishwanath A, Quaiser S, Khan R. Role of high‑sensitivity C‑reactive protein measurements in HIV patients. Indian J Sex Transm Dis AIDS. 2016;37(2):123–128.
   PubMedGoogle Scholar
• Nkinda L, Patel K, Njuguna B, et al. C-reactive protein and interleukin-6 levels among human immunodeficiency virus-infected patients with dysglycemia in Tanzania. BMC Endocr Disord. 2019;19:1–8.
   PubMed Web of Science ®Google Scholar
• Tan DHS, Rolon MJ, Figueroa MI, et al. Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: substudy of a randomized trial. PLOS One. 2019;310:1–13.
   Google Scholar
• Genetu K, Abere K, Tachbele E. Magnitudes and correlates of human immunodeficiency virus, hepatitis B virus, and syphilis among pregnant mothers attending antenatal care in Addis Ababa, Ethiopia. Infect Dis Obstet Gynecol. 2022;2022:6156613.
   PubMedGoogle Scholar
• Shiferaw MB, Tulu KT, Zegeye AM, et al. Liver enzymes abnormalities among highly active antiretroviral therapy experienced and HAART naïve HIV-1 infected patients at Debre Tabor Hospital, North West Ethiopia: a comparative cross-sectional study. AIDS Res Treat. 2016;2016:1–7. doi: 10.1155/2016/1985452.
   Google Scholar
• Gebremicael G, Tola HH, Gebreegziaxier A, et al. Incidence of hepatotoxicity and factors associated during highly active antiretroviral therapy in people living with HIV in Ethiopia: a prospective cohort study. HIV AIDS. 2021;13:329–336. doi: 10.2147/HIV.S283076.
   Google Scholar
• FMOH Ethiopia. National consolidated guidelines for comprehensive HIV prevention, care and treatment. Fmoh; 2018. p. 1–238 [Online]. Available from: file:///C:/Users/Tere/Desktop/University of South Africa (17-2017)/Documents on Cervical Cancer/July 22,2017/All Litratures/National Comprehensive HIV Care Guideline 2018.pdf
   Google Scholar
• Ethiopian Public Health Institute. HIV related estimates and projections in Ethiopia for the year 2021–2022. Addis Ababa: Ethiopian Public Health Institute; 2021.
   Google Scholar
• Liu Y, Zeng P, Wang J, et al. Hepatitis B virus infection in a cohort of HIV infected blood donors and AIDS patients in Sichuan, China. J Transl Med. 2014;12(1):1–8.
   PubMedGoogle Scholar
• Liu M, Li L, Zhao J, et al. Gender differences in demographic and clinical characteristics in patients with HBV-related liver diseases in China. PeerJ. 2022;10:e13828. doi: 10.7717/peerj.13828.
   PubMed Web of Science ®Google Scholar
• The DHS Program. Ethiopia demographic and health survey; 2016 [Online]. Available from: https://dhsprogram.com/pubs/pdf/FR328/FR328.pdf
   Google Scholar
• Shegaw F, Yibeltal D, Tessema Z. Prevalence of HIV/AIDS among elderly people and associated factors in Habru Woreda, Amhara Region, Northeast Ethiopia. HIV/AIDS Res Palliat Care. 2020;12:411–423.
   Google Scholar
• Mdlalose N, Naidoo K, Yende-Zuma N, et al. High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa. BMC Infect Dis. 2020;20:1–9.
   Web of Science ®Google Scholar
• Teame G, Gebreyesus A, Tsegay E, et al. Hepatitis B and C viral coinfections and their association with HIV viral load suppression among HIV‑1 infected patients on ART at Mekelle Hospital, Northern Ethiopia. AIDS Res Ther. 2022;19:1–10.
   PubMed Web of Science ®Google Scholar
• World Health Organization. C-reactive protein concentrations as a marker of inflammation or infection for interpreting biomarkers of micronutrient status. Vitamin and Mineral Nutrition Information System; 2014. p. 1–4 [Online]. Available from: http://apps.who.int/iris/bitstream/10665/133708/1/WHO_ NMH_NHD_EPG_14.7_eng.pdf?ua=1
   Google Scholar
• Viegas EO, Tembe N, Macovela E, et al. Incidence of HIV and the prevalence of HIV, hepatitis B and syphilis among youths in Maputo, Mozambique: a cohort study. PLOS One. 2015;10:1–15.
   Web of Science ®Google Scholar
• Cheng Z, Lin P, Cheng N. HBV/HIV coinfection: impact on the development and clinical treatment of liver diseases. Front Med. 2021;8(October):1–15. doi: 10.3389/fmed.2021.713981.
   Google Scholar
• Wu P-Y, Chen M-Y, Hsieh S-M, et al. Comorbidities among the HIV-infected patients aged 40 years or older in Taiwan. PLOS One. 2014;9(8):e104945. doi: 10.1371/journal.pone.0104945.
   PubMed Web of Science ®Google Scholar
• Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004;18(15):2075–2079. doi: 10.1097/00002030-200410210-00012.
   PubMed Web of Science ®Google Scholar
• Sadiq ST, McSorley J, Copas AJ, et al. The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen. Sex Transm Infect. 2005;81(5):380–385. doi: 10.1136/sti.2004.012914.
   PubMed Web of Science ®Google Scholar
• Boulware DR, Hullsiek KH, Puronen CE, et al. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis. 2011;203(11):1637–1646. doi: 10.1093/infdis/jir134.
   PubMed Web of Science ®Google Scholar